Rationale Chemotherapy-induced cognitive impairment (CICI), chemobrain, and chemofog
are the common terms for mental dysfunction in a cancer patient/survivor under the influence …

There are various cancer treatments at present, and chemotherapy is one of the main
methods. Chemotherapy‐related cognitive impairment (CRCI), as one of the side effects of …

Chemotherapeutic agents may adversely affect the nervous system, including the neural
precursor cells as well as the white matter. Although the mechanisms are not completely …

Objective To investigate neurotoxicity clinical and instrumental features, incidence, risk
factors, and early and long-term prognosis in lymphoma patients who received CAR T-cell …

Breast cancer is the most common female malignancy in both the developed and
developing world. Doxorubicin is one of the most commonly used chemotherapies for breast …

In Europe, an estimated 4 million new cancer cases were diagnosed in 2020 (ECIS-
European Cancer Information System, 2023). Patients' chances of survival improved …

Chemo-brain refers to the thinking and memory problems that occur in cancer patients
during and after chemotherapy. It is also known as cognitive dysfunction or chemo-fog. Risk …

Neuroinflammation is one of the major pathological factors leading to Alzheimer's disease
(AD). The role of microglial cells in neuroinflammation associated with AD has been known …

Abstract In 2015, the United States Food and Drug Administration (FDA) approved uridine
triacetate to treat overdose and severe toxicity of the fluoropyrimidine chemotherapy agents …

Chemotherapy-induced cognitive impairment (CICI) has been observed in a large fraction of
cancer survivors. Although many of the chemotherapeutic drugs do not cross the blood …